Acute migraine medications and evolution from episodic to chronic migraine: A longitudinal population-based study

Headache

Volumn 48, Issue 8, 2008, Pages 1157-1168

  Bigal, Marcelo E ^a,b,g   Serrano, Daniel ^c   Buse, Dawn ^d   Scher, Ann ^e   Stewart, Walter F ^f   Lipton, Richard B ^b,d  

^a MERCK RESEARCH LABORATORIES   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d MONTEFIORE MEDICAL CENTER   (United States)

^e Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^f Center for Health Research and Rural Advocacy   (United States)

^g NONE   (United States)

Author keywords

Chronic migraine; Medication overuse; Migraine progression; Transformed migraine

Indexed keywords

ACETYLSALICYLIC ACID; BARBITURIC ACID DERIVATIVE; BUTALBITAL; CAFFEINE; ERGOTAMINE; ISOMETHEPTENE; NARCOTIC ANALGESIC AGENT; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; TRIPTAN DERIVATIVE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; DEMOGRAPHY; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; DRUG INDUCED HEADACHE; DRUG UTILIZATION; FEMALE; FOLLOW UP; HUMAN; INCOME; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; QUESTIONNAIRE; RACE; RISK FACTOR; SEX RATIO; STATISTICAL ANALYSIS; TRANSFORMED MIGRAINE; URBANIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALGESICS; CHRONIC DISEASE; COMMUNITY HEALTH PLANNING; DISEASE PROGRESSION; FEMALE; HEALTH SURVEYS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MIGRAINE DISORDERS; ODDS RATIO; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 51549110159     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2008.01217.x     Document Type: Article

References (34)

1. Headache Classification. Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. 2nd edn. Cephalalgia. 2004 24 (Suppl. 1 1 160.
2. Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: Field trial of revised IHS criteria. Neurology. 1996 47 : 871 875.
3. Classification H, Olesen J, Bousser MG, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006 26 : 742 746.
4. Scher AI, Stewart WF, Ricci JA, Lipton RB. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain. 2003 106 : 81 89.
5. Castillo J, Muñoz P, Guitera V, Pascual J. Epidemiology of chronic daily headache in the general population. Headache. 1999 39 : 190 196.
6. Silberstein SD, Silberstein JR. Chronic daily headache: Long-term prognosis following inpatient treatment with repetitive IV DHE. Headache. 1992 32 : 439 445.
7. Katsarava Z, Schneeweiss S, Kurth T, et al. Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology. 2004 62 : 788 790.
8. Bigal ME, Lipton RB. Modifiable risk factors for migraine progression (or for chronic daily headaches) - clinical lessons. Headache. 2006 46 (Suppl. 3 S144 S146.
9. Mathew NT. Drug-induced headache. Neurol Clin. 1990 8 : 903 912.
10. Bigal ME, Rapoport AM, Sheftell FD, et al. Transformed migraine and medication overuse in a tertiary headache centre - clinical characteristics and treatment outcomes. Cephalalgia. 2004 24 : 483 490.
11. Rapoport A, Stang P, Gutterman DL, et al. Analgesic rebound headache in clinical practice: Data from a physician survey. Headache. 1996 36 : 14 19.
12. Dodick DW. Debate: Analgesic overuse is a cause, not consequence, of chronic daily headache. Analgesic overuse is not a cause of chronic daily headache. Headache. 2002 42 : 547 554.
13. Tepper SJ. Debate: Analgesic overuse is a cause, not consequence, of chronic daily headache. Analgesic overuse is a cause of chronic daily headache. Headache. 2002 42 : 543 547.
14. Sarchielli P, Di Filippo M, Nardi K, Calabresi P. Sensitization, glutamate, and the link between migraine and fibromyalgia. Curr Pain Headache Rep. 2007 11 : 343 351.
15. Rome HP Jr., Rome JD. Limbically augmented pain syndrome (LAPS): Kindling, corticolimbic sensitization, and the convergence of affective and sensory symptoms in chronic pain disorders. Pain Med. 2000 1 : 7 23.
16. Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007 68 : 343 349.
17. Lipton RB, Bigal ME, Burstein R, et al. Cutaneous allodynia in the migraine population. Ann Neurol. 2008 63 : 148 158.
18. Bigal ME, Tsang A, Loder E, Serrano D, Reed ML, Lipton RB. Body mass index and episodic headaches: A population-based study. Arch Intern Med. 2007 167 : 1964 1970.
19. Silberstein S, Loder E, Diamond S, et al. Probable migraine in the United States: results of the American Migraine Prevalence and Prevention (AMPP) study. Cephalalgia. 2007 27 : 220 234.
20. Liebestein M, Bigal ME, Sheftell FD, et al. Validation of the chronic daily headache questionnaire. Neurology. 2007 68 (Suppl. 1 369.
21. Compton WM, Volkow ND. Major increases in opioid analgesic abuse in the United States: Concerns and strategies. Drug Alcohol Depend. 2006 81 : 103 107.
22. Compton WM, Stein JB, Robertson EB, Pintello D, Pringle B, Volkow ND. Charting a course for health services research at the National Institute on drug abuse. J Subst Abuse Treat. 2005 29 : 167 172.
23. Zwart JA, Dyb G, Hagen K, et al. Analgesic overuse among subjects with headache, neck, and low-back pain. Neurology. 2004 62 : 1540 1544.
24. Wilkinson SM, Becker WJ, Heine JA. Opiate use to control bowel motility may induce chronic daily headache in patients with migraine. Headache. 2001 41 : 303 309.
25. Bahra A, Walsh M, Menon S, Goadsby PJ. Does chronic daily headache arise de novo in association with regular use of analgesics? Headache. 2003 43 : 179 190.
26. Paemeleire K, Bahra A, Evers S, Matharu MS, Goadsby PJ. Medication-overuse headache in patients with cluster headache. Neurology. 2006 67 : 109 113.
27. Welch KMA, Nagesh V, Aurora SK, Gelman N. Periaqueductal gray matter dysfunction in migraine: Cause or the burden of illness? Headache. 2001 41 : 629 637.
28. Burstein R, Cutrer MF, Yarnitsky D. The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain. 2000 123 : 1703 1709.
29. Bigal ME, Lipton RB. Concepts and mechanisms of migraine chronification. Headache. 2008 48 : 7 15.
30. McGeer PL, McGeer EG. Glial reactions in Parkinson's disease. Mov Disord. 2008 23 : 474 483.
31. Wahner AD, Bronstein JM, Bordelon YM, Ritz B. Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease. Neurology. 2007 69 : 1836 1842.
32. Weggen S, Rogers M, Eriksen J. NSAIDs: Small molecules for prevention of Alzheimer's disease or precursors for future drug development? Trends Pharmacol Sci. 2007 28 : 536 543 Epub 2007 Sep 27
33. Jakubowski M, Levy D, Kainz V, Zhang XC, Kosaras B, Burstein R. Sensitization of central trigeminovascular neurons: Blockade by intravenous naproxen infusion. Neuroscience. 2007 148 : 573 583 Epub 2007 Jul 25 ].
34. Center for Disease Control and Prevention. Substance Abuse. Available at: http://www.cdc.gov/correctionalhealth/specialtopics.htm. Accessed December 16, 2007.